{"SPADE_UN_01073": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2005/0049182 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2005_0049182_A1", "Patent Type": "Patent Application", "Publication Date": "2005-3-3", "Family Info": "CA2456477A1,DE60239707D1,EP1469876A2,EP1469876B1,US6835536,US8138144,US20030171281,US20120202735,WO2003015809A2,WO2003015809A3,WO2003015809A", "Patent Title": "Antimicrobial cationic peptides and formulations thereof.", "Abstract": "Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."}, {"Patent No": "US 6835536 B2", "Patent Link": "http://www.lens.org/lens/patent/US_6835536_B2", "Patent Type": "Granted Patent", "Publication Date": "2004-12-28", "Family Info": "US4510132,US6503881,US6538106,EP590070,WO9112815,WO0000214,WO0071175", "Patent Title": "Antimicrobial Cationic Peptides And Formulations Thereof", "Abstract": "Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganismcaused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."}, {"Patent No": "US 8927487 B2", "Patent Link": "http://www.lens.org/lens/patent/US_8927487_B2", "Patent Type": "Granted Patent", "Publication Date": "2015-1-6", "Family Info": "US20130296227A1,US13421018,US10865687,US10225087,US60314232,US8466102,EP0930065,WO03015809", "Patent Title": "Antimicrobial cationic peptides and formulations thereof", "Abstract": "Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganismcaused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."}], "Sequence Information": {"SPADE ID": "SPADE_UN_01073", "Sequence": "ILKWVWWVWRRK", "Sequence Length": 12, "Peptide Name": "Sequence 34 from Patent US 20050049182", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "WKR", "Absent Amino Acids": "ACDEFGHMNOPQSTUY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 8, "Polar Residues": 6, "Positive Residues": 4, "Negative Residues": 0, "Mass": 1756.15, "PI": 12.0, "Net Charge": 4, "Hydrophobicity": -0.31, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_05457", "Similarity": 1.0, "Sequence": "VWRRKKYWR"}, {"SPADE_ID": "SPADE_UN_05192", "Similarity": 1.0, "Sequence": "WRRKIVRVW"}, {"SPADE_ID": "SPADE_UN_05628", "Similarity": 1.0, "Sequence": "WRRKWWSRW"}]}}}